Best Paper Award (2000 EUR) AEPC WG Pulmonary Hypertension, Heart Failure and Transplantation
Best Paper Award (2000 EUR)
AEPC WG Pulmonary Hypertension, Heart Failure and Transplantation
AEPC Congress, Gothenburg May 13-16, 2020
AEPC members, who are either trainees or junior faculty. The “best paper selection committee” will meet in Gothenburg in May 2020 to discuss each submitted manuscript, and elect the winner of this Award (2000 EUR).
Eligibility Criteria for the Best Paper Award, WG PHHFTx are the following:
The Applicant must be:
1.) AEPC member
2.) First author of the submitted original article
3.) Not senior faculty (i.e. graduate student, PostDoc, resident, fellow, junior faculty = Definition of junior faculty: less than 5 years on faculty)
4.) Level of acceptance: Papers (Original Articles) in press are accepted for selection,
5.) Papers (Original Articles) published/in press 2018 or later will be accepted for selection!
6.) Applications (Cover Letter + CV + Original Article in one pdf file with a size of < 10MB, publication list) need to be submitted as Email-attachment by April 1, 2020, to
Prof. Dr. Martin Koestenberger (email@example.com)
Prof. Dr. Georg Hansmann (firstname.lastname@example.org)
- The selection committee may decide not to grant the award in any given year, based on the submissions.
- The chair of the selection selection committee will not be a member of the WG PHHFTX.
Criteria for high best paper scores at AEPC Gothenburg 2020 are:
- well-conducted, hypothesis driven, basic-translational science studies that are meaningful for human disease and/or unravel new pathobiological or therapeutic mechanisms
- prospective, hypothesis-driven clinical studies including a comparative group (as opposed to historical controls)
- large, well-conducted retrospective studies that yield conclusions that are useful for patient care
- large, patient registries that address a relevant clinical question
Abstracts we do not score at all or do not give high scores, for the best oral abstract session (WG PHHFTX):
- case reports
- case series
- small retrospective studies (usually < 50 patients)
- retrospective studies that are entirely descriptive in nature and do not allow any clinically relevant conclusions.
- prospective studies that have limited patient enrollment or other errors in the study design and as such are not conclusive (underpowered studies)
- basic science or genetic studies that do not deal directly with "pulmonary hypertension", "heart failure", "ventricular dysfunction" or other strongly-related areas of research
- abstracts that have been presented in identical or similar form at AEPC congress or any other preceding international meeting
- abstracts that have been published or which include > 50% data that have been published
- abstracts that do not have a student, resident, fellow or junior faculty as presenter and first author.
- abstracts that contain published data to a significant extend